HR 4449 United States House · 118th Congress

Pharmaceutical Security Production Act

Summary
Pharmaceutical Security Production Act This bill establishes the Commission on Strengthening the Domestic Pharmaceutical Supply Chain. The commission must assess the security and vulnerabilities of the domestic pharmaceutical supply chain in the United States and recommend improvements, including by developing metrics for domestic manufacturing programs, proposing solutions to strengthen the domestic manufacturing workforce, and evaluating ways to support a financial market for domestically manufactured products. The commission terminates four years after the bill is enacted.
Bill status in committee 1 of 4 stages cleared
Introduction
Jun 2023
Committee Review
Floor Vote
President
Introduced Jun 30, 2023 Last action Jul 7, 2023
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
3
Key actions
0
Committee
2
Jul 7, 2023
Committee
Referred to the Subcommittee on Health.
lower
Jun 30, 2023
Committee
Referred to the House Committee on Energy and Commerce.
lower
Jun 30, 2023
Introduced
Introduced in House
lower
1 primary · 2 co-sponsors

Sponsors